Cargando…
PARP1 proximity proteomics reveals interaction partners at stressed replication forks
PARP1 mediates poly-ADP-ribosylation of proteins on chromatin in response to different types of DNA lesions. PARP inhibitors are used for the treatment of BRCA1/2-deficient breast, ovarian, and prostate cancer. Loss of DNA replication fork protection is proposed as one mechanism that contributes to...
Autores principales: | Mosler, Thorsten, Baymaz, H Irem, Gräf, Justus F, Mikicic, Ivan, Blattner, Georges, Bartlett, Edward, Ostermaier, Matthias, Piccinno, Rossana, Yang, Jiwen, Voigt, Andrea, Gatti, Marco, Pellegrino, Stefania, Altmeyer, Matthias, Luck, Katja, Ahel, Ivan, Roukos, Vassilis, Beli, Petra |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9723622/ https://www.ncbi.nlm.nih.gov/pubmed/36350633 http://dx.doi.org/10.1093/nar/gkac948 |
Ejemplares similares
-
Dormant origins and fork protection mechanisms rescue sister forks arrested by transcription
por: Brambati, Alessandra, et al.
Publicado: (2018) -
Cockayne syndrome group B protein regulates fork restart, fork progression and MRE11-dependent fork degradation in BRCA1/2-deficient cells
por: Batenburg, Nicole L, et al.
Publicado: (2021) -
Stability of blocked replication forks in vivo
por: Mettrick, Karla A., et al.
Publicado: (2016) -
PARP inhibitors trap PARP2 and alter the mode of recruitment of PARP2 at DNA damage sites
por: Lin, Xiaohui, et al.
Publicado: (2022) -
PARP-2 and PARP-3 are selectively activated by 5′ phosphorylated DNA
breaks through an allosteric regulatory mechanism shared with PARP-1
por: Langelier, Marie-France, et al.
Publicado: (2014)